• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2010-2019  
Title Created Date
New somatostatin-drug conjugates for effective targeting pancreatic cancer 20 July 2018
Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: In vivo and in vitro studies 19 July 2018
An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with 177Lu-DOTATATE for the treatment of neuroblastoma 19 July 2018
Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual status of cancer patients 18 July 2018
Vitamin D and DDX4 regulate the proliferation and invasion of ovarian cancer cells 16 July 2018
Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancer 13 July 2018
Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis 13 July 2018
Somatostatin Octapeptide Inhibits Cell Invasion and Metastasis in Hepatocellular Carcinoma Through PEBP1 12 July 2018
Growth hormone-releasing hormone (GHRH) promotes metastatic phenotypes through EGFR/HER2 transactivation in prostate cancer cells 12 July 2018
Expression of Somatostatin Type-2 and -4 Receptor and Correlation with Histological Type in Breast Cancer 10 July 2018
Display # 

Page 76 of 172

  • Start
  • Prev
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • Next
  • End

Search

Follow us...

Latest

  • Melatonin: A Powerful Integrative Adjunctive Agent for Oncology
  • Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
  • Melatonin in cancer management: progress and promise
  • Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats
  • Protective effects of melatonin and vitamin E in brain damage due to gamma radiation: an experimental study
  • Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
  • The impact of vitamin D on cancer: A mini review
  • Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
  • Radio-Protective Effects of Melatonin on Subventricular Zone in Irradiated Rat: Decrease in Apoptosis and Upregulation of Nestin
  • Modulating effects of famotidine and melatonin on high dose radiation induced cell lethality in normal human and cancer cell lines
  • Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo
  • Melatonin: an endogenous miraculous indolamine, fights against cancer progression
  • Melatonin: An Endogenous Antiestrogen with Oncostatic Properties
  • Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
  • Disease Control after Androgen Deprivation Therapy Combined with Di Bella Multitherapy
  • Somatostatin and Somatostatin Receptors in Tumour Biology
  • Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
  • Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer